A detailed history of Cibc Bancorp Usa Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 23,312 shares of OCUL stock, worth $265,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,312
Holding current value
$265,057
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 21, 2025

SELL
$9.09 - $13.6 $75,692 - $113,247
-8,327 Reduced 35.72%
14,985 $175,000
Q3 2025

Nov 12, 2025

BUY
$9.09 - $13.6 $211,906 - $317,043
23,312 New
23,312 $272,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $875M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Cibc Bancorp Usa Inc. Portfolio

Follow Cibc Bancorp Usa Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Bancorp Usa Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc Bancorp Usa Inc. with notifications on news.